with untreated AML cytarabine/daunorubicin, vs cytarabine/daunorubicin in older adults Phase 2 trial of CPX-351, a fixed 5:1 molar ratio of

2014 
    • Correction
    • Cite
    • Save
    • Machine Reading By IdeaReader
    27
    References
    0
    Citations
    NaN
    KQI
    []